Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle rad51'

Search results for: 'research area cell cycle rad51'

Items 531-540 of 557

Page
per page
  1. Potassium Canrenoate
    A8506 Potassium Canrenoate
    Target: Aldosterone receptor
    Summary: Aldosterone antagonist
      insoluble in EtOH; insoluble in DMSO; ≥117.4 mg/mL
  2. MK-0752
    A4006 MK-0752
     1 Citation
    Summary: γ-secretase inhibitor
      ≥22.15 mg/mL
  3. PF-04620110
    A4384 PF-04620110
    Summary: DGAT-1 inhibitor,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥16.9 mg/mL
  4. PR-619
    A8212 PR-619
    Target: Deubiquitinating enzymes (DUBs)
    Summary: Deubiquitylating enzymes (DBUs) inhibitor
      insoluble in H2O; insoluble in EtOH; ≥11.15 mg/mL
  5. Ramelteon
    A1748 Ramelteon
     1 Citation
    Target: Melatonin Receptors
    Summary: Agonist of melatonin receptor(M1-M2),highly selective
      insoluble in H2O; ≥12.95 mg/mL
  6. CAL-101 (Idelalisib, GS-1101)
    A3005 CAL-101 (Idelalisib, GS-1101)
     2 Citation
    Target: PI3K
    Summary: PI3K inhibitor
  7. 2-Methoxyestradiol (2-MeOE2)
    A4188 2-Methoxyestradiol (2-MeOE2)
     2 Citation
    Summary: Apoptotic, antiproliferative and antiangiogenic agent
      insoluble in H2O; ≥15.25 mg/mL
  8. PHA-680632
    A4122 PHA-680632
    Target: Aurora Kinases|PLK|FGFR
    Summary: Aurora kinase inhibitor,novel and potent
      ≥50.2 mg/mL
  9. AM966
    A3170 AM966
     2 Citation
    Target: LPA Receptors
    Summary: LPA1 antagonist, oral active, high affinity, selective,
      ≥24.55 mg/mL
  10. Puromycin dihydrochloride
    B7587 Puromycin dihydrochloride
    Summary: allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene.
      ≥27.2 mg/mL

Items 531-540 of 557

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 34item
  2. Apoptosis 63item
  3. Chromatin/Epigenetics 75item
  4. Metabolism 24item
  5. MAPK Signaling 18item
  6. Tyrosine Kinase 41item
  7. DNA Damage/DNA Repair 49item
  8. PI3K/Akt/mTOR Signaling 28item
  9. Microbiology & Virology 14item
  10. Cell Cycle/Checkpoint 84item
  11. Ubiquitination/ Proteasome 18item
  12. JAK/STAT Signaling 25item
  13. TGF-β / Smad Signaling 23item
  14. Angiogenesis 6item
  15. GPCR/G protein 21item
  16. Stem Cell 45item
  17. Membrane Transporter/Ion Channel 19item
  18. Cancer Biology 18item
  19. Endocrinology and Hormones 7item
  20. Neuroscience 16item
  21. Obesity, Appetite Control & Diabetes 2item
  22. Other Signal Transduction 12item
  23. Others 50item
  24. Immunology/Inflammation 18item
  25. Cardiovascular 5item
  26. Vitamin D Related 3item
  27. NF-κB 1 item
Specificity
  1. Selective 173item
Reversibility
  1. Reversible 23item
  2. Irreversible 9item
Target
  1. Caspases 8item
  2. Cyclin-Dependent Kinases 16item
  3. Proteasome 7item
  4. Cathepsins 1 item
  5. Histone Deacetylases (HDACs) 15item
  6. Inhibitor of apoptosis proteins (IAP) 1 item
  7. Akt 1 item
  8. Bcl-2 2item
  9. PI3K 5item
  10. Raf 2item
  11. Aurora Kinases 6item
  12. Bcl-xl 1 item
  13. Glycoproteins 1 item
  14. MDM2 1 item
  15. EZH2 3item
  16. mTOR 2item
  17. Bromodomains 1 item
  18. AP-1 2item
  19. MMP 1 item
  20. Myosin II ATPases 1 item
  21. FLT3 2item
  22. GSK-3 4item
  23. LPA Receptors 1 item
  24. P-glycoprotein (P-gp) 3item
  25. PLK 7item
  26. Chk 4item
  27. VEGFR 4item
  28. PDGFR 3item
  29. c-Kit 1 item
  30. Bromodomain-containing proteins(BRDs) 1 item
  31. Phosphodiesterases (PDEs) 2item
  32. Hydrolase 1 item
  33. p38 1 item
  34. Bcr-Abl 1 item
  35. MEK 2item
  36. PORCN 1 item
  37. DOT1L 1 item
  38. FGFR 2item
  39. Glucagon-like peptide 1 (GLP-1) receptors 1 item
  40. Sir2-like Family Deacetylases (Sirtuins) 1 item
  41. Deubiquitinating enzymes (DUBs) 1 item
  42. Smoothened 2item
  43. Eukaryotic elongation factors 1 item
  44. Src 2item
  45. Trk Receptors 1 item
  46. STAT 3item
  47. Microtubules/Tubulins 4item
  48. Estrogen and Related Receptors 1 item
  49. EGFR 7item
  50. Hedgehog 1 item
  51. Reverse Transcriptases 1 item
  52. ROCK 7item
  53. JAK 5item
  54. p300 1 item
  55. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  56. Syk 1 item
  57. DNA-PK 2item
  58. HSP90 1 item
  59. AMPK 2item
  60. CFTR 3item
  61. TNKS 1 item
  62. ErbB 2item
  63. Toll-like receptors (TLRs) 2item
  64. DNA Methyltransferases 1 item
  65. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  66. ERK 1 item
  67. BMI-1 1 item
  68. PKC 5item
  69. Ca2 /calmodulin-dependent protein kinases (CaMKs) 2item
  70. Lyn 1 item
  71. SGLT 1 item
  72. RAD51 2item
  73. USP 1 item
  74. LRRK2 2item
  75. Voltage-gated Calcium Channels (CaV) 1 item
  76. ALK 1 item
  77. Sphingosine kinases (SphKs) 1 item
  78. GTPases 1 item
  79. PKA 3item
  80. Fatty-acid-binding proteins (FABPs) 1 item
  81. Tie-2 1 item
  82. Free Fatty Acid Receptors 1 item
  83. phosphatases 1 item
  84. Autophagy 2item
  85. ATM/ATR 4item
  86. CK1 1 item
  87. Farnesyl Diphosphate Synthases 1 item
  88. Melatonin Receptors 1 item
  89. MAGL 1 item
  90. NPY Receptors 1 item
  91. c-Fyn 1 item
  92. Histamine H1 Receptors 2item
  93. RAR/RXR 1 item
  94. TRP Channel 1 item
  95. DYRK 1 item
  96. Apoptosis Inducers 1 item
  97. MNK 1 item
  98. NO Donors / Precursors 1 item
  99. Glucocorticoid Receptors 1 item
  100. IL Receptors 1 item
  101. 15-lipoxygenases 1 item
  102. Inward Rectifier Potassium (Kir) Channels 1 item
  103. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  104. NMDA receptor 1 item
  105. Aldosterone receptor 1 item
  106. DPP-4 1 item
  107. DREADD Ligands 1 item
  108. p70 rsk 1 item
  109. Microtubule/Tubulin 1 item
  110. p53-MDM2 interaction 1 item
  111. KDR 1 item
  112. p53 3item
  113. c-Fms tyrosine kinase 1 item
  114. insulin 1 item
  115. Ub-conjugating enzyme (E2) complex 1 item
  116. Smoothened receptor 1 item
  117. PPAR 1 item
  118. HDM2 ubiquitin ligase 1 item
  119. Vitamin D receptors (VDRs) 1 item
  120. Antibiotic 1 item
  121. DNA Alkylating 1 item
  122. GLI 1 item
  123. Stem Cell Differentiation 1 item
  124. PP2A/Nkd interaction 1 item
  125. adrenergic receptor 1 item
  126. Ribonucleotide Reductases 1 item
  127. Aryl hydrocarbon receptors (AHRs) 1 item
  128. DCLK2 1 item
  129. phosphatidylinositol kinase 1 item
  130. Lck 1 item
  131. Adenosine Deaminases 1 item
  132. Histamine receptors 1 item
  133. GluR 1 item
  134. 5-HT receptor 1 item
  135. dopamine receptors 1 item
  136. AMPA receptor 1 item
  137. Flk1 1 item
  138. p21 1 item
  139. RHA 1 item
  140. TRPC channel 1 item
  141. FKBP 1 item
  142. Bcl-w 1 item
  143. PPK 1 item
  144. c-Syk 1 item
  145. CDK1/CyclinB 1 item
  146. FXR 1 item
  147. Vascular Disrupting Agents (VDA) 1 item
  148. ATM 1 item
  149. Sirtuin 1 item
  150. PIKfyve 1 item
  151. Bax 1 item
  152. NS3/4a Proteases 1 item
  153. p90 S6K 1 item
Reported Experiments
  1. Animal Experiments 217item
  2. Cell Experiments 170item
Related Disease
  1. Acne 1 item
  2. Acute Myelogenous Leukemia 1 item
  3. Acute Myeloid Leukemia 7item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 4item
  6. B-lymphoid Malignancies 1 item
  7. Breast Cancer 36item
  8. Cancer 136item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 2item
  11. Colon Cancer 14item
  12. Colon Carcinoma 1 item
  13. Colorectal Cancer 15item
  14. Diabetes 3item
  15. Fungal Infection 1 item
  16. Glioblastoma 7item
  17. Glioma 2item
  18. HCV 1 item
  19. Hepatocellular Carcinoma 3item
  20. HIV 1 item
  21. Immunosuppressive Therapy 1 item
  22. Inflammatory Diseases 3item
  23. Leukemia 6item
  24. Liver Cancer 2item
  25. Lung Cancer 6item
  26. Lymphoma 4item
  27. Mantle Cell Lymphoma 2item
  28. Medulloblastoma 1 item
  29. Melanoma 11item
  30. Mixed Lineage Leukemia 1 item
  31. Multiple Myeloma 6item
  32. Neuroblastoma 2item
  33. Non-small Cell Lung Cancer 6item
  34. Non-small Cell Lung Carcinoma 1 item
  35. Ovarian Cancer 10item
  36. Pain Relief 1 item
  37. Pancreatic Cancer 11item
  38. Pancreatic Carcinoma 2item
  39. Prostate Cancer 14item
  40. Psoriasis 2item
  41. Pulmonary Fibrosis 1 item
  42. Renal Cell Carcinoma 2item
  43. Rheumatoid Arthritis 2item
  44. Sleep Disorders 1 item
  45. Type 2 Diabetes 3item